Of every peptide we ship out of our Dubai facility, tesamorelin is the one researchers regret tracking incorrectly. They weigh themselves, they pinch their waist, they squint at the mirror — and they conclude the molecule "isn't working." Then a DEXA scan at week 26 shows a 17 to 18 percent drop in VAT (visceral adipose tissue), exactly in line with what Stanley and colleagues reported in 2014. Tesamorelin doesn't shave subcutaneous fat off your arms. It dissolves the metabolically lethal fat wrapped around your liver, pancreas and mesentery — and DEXA is the only at-clinic tool in the UAE that can see it move. If you're sourcing tesamorelin Dubai or anywhere across the emirates and you want defensible, publishable data, this is the protocol. REVIVE LAB UAE keeps tesamorelin 5 mg and 10 mg vials in stock at the Dubai lab for same day delivery, and we wrote this guide because most buyers in the UAE order the peptide without ever scheduling the imaging that would prove what it did. That ends today. Looking to buy tesamorelin UAE with 24h delivery? Skip ahead to the emirate delivery table or order tesamorelin Dubai direct from REVIVE — otherwise, read on for the full DEXA tracking blueprint.
Tesamorelin is a stabilized 44-amino-acid analog of growth hormone releasing hormone (GHRH). It binds the GHRH receptor on somatotrophs in the anterior pituitary and produces a pulsatile, physiological release of endogenous growth hormone (GH) — which is the critical distinction from exogenous recombinant GH. Pulsatile GH signals to hepatic IGF-1 production and, downstream, to lipolysis in adipose tissue. The clinically distinctive feature, repeatedly demonstrated in the HIV-associated lipodystrophy trials, is that the lipolytic effect is disproportionately localized to visceral fat depots rather than subcutaneous compartments.
Falutz and colleagues published the foundational 26-week phase III data in 2007, showing a roughly 15 percent reduction in VAT versus a slight increase in the placebo arm, with no meaningful change in subcutaneous abdominal adipose tissue (SAT). Falutz 2010 extended the observation through 52 weeks and demonstrated that the VAT loss was sustained only while subjects continued dosing — a critical fact for any UAE researcher planning a long-arc protocol. Stanley and colleagues in 2014 then drilled into the mechanism, showing that tesamorelin's VAT reduction tracked with improvements in hepatic steatosis (NAFLD) on MRI proton density fat fraction — meaning the visceral effect extends to ectopic liver fat, not just intra-abdominal depots.
The reason this matters for DEXA tracking in the UAE: every other body composition tool you can access in Dubai or Abu Dhabi will undersell what tesamorelin actually does. A scale will move one to three kilograms. Calipers will say nothing. A waist tape might shrink one to two centimetres. But the DEXA — particularly the regional VAT estimation algorithm available on GE Lunar iDXA and Hologic Horizon machines at major Dubai imaging centres — will detect a 130 to 220 cm-cubed reduction in visceral fat volume at week 26 in a responder. That is the data you came for.
Here is the cadence we recommend to research clients buying tesamorelin Dubai or shipping to Abu Dhabi, Sharjah and the northern emirates. It mirrors the imaging timeline of Falutz 2007 (baseline, week 26) and Stanley 2014 (baseline, week 26) but adds a midpoint check at week 13 because UAE researchers — unlike pharma-trial participants — usually want to know early whether they're a responder.
| Timepoint | Scan | Expected VAT change (responder) | Markers also worth pulling |
|---|---|---|---|
| Week 0 (baseline) | DEXA + VAT region | — | Fasting IGF-1, fasting glucose, HbA1c, fasting insulin, ALT, triglycerides, waist circumference |
| Week 13 | DEXA + VAT region | ~7 to 10% VAT reduction | IGF-1 (confirm elevation into upper-quartile range), fasting glucose |
| Week 26 | DEXA + VAT region | ~15 to 18% VAT reduction (Stanley 2014 / Falutz 2007 magnitude) | IGF-1, HbA1c, ALT, triglycerides — and ideally MRI-PDFF for hepatic fat if budget allows |
| Week 52 | DEXA + VAT region | VAT loss maintained on continued dosing; rebound documented within 26 weeks of cessation (Falutz 2010) | Full repeat panel; decide on continuation |
A few protocol notes from what we see across UAE research logs. First, IGF-1 should rise into the upper-quartile age-adjusted range within four to eight weeks — if it doesn't, dose timing or reconstitution technique is usually the issue, not the molecule. Second, the VAT signal at week 13 is real but noisy; do not abandon a protocol on a flat week-13 scan if IGF-1 is responding. Third, the Stanley 2014 cohort that responded best had baseline VAT above approximately 158 cm-squared on cross-section — meaning tesamorelin's effect size scales with how much visceral fat there is to lose. Lean research subjects with low baseline VAT will see proportionally smaller absolute changes.
For a 26-week DEXA-tracked protocol at the published research dose of 2 mg subcutaneous daily, a researcher will need 364 mg of tesamorelin. From our UAE inventory that translates to 73 vials of tesamorelin 5 mg or 37 vials of tesamorelin 10 mg. We ship both presentations cold-chain from the Dubai facility, paired with BAC water 3 mL for reconstitution. Bulk-stocking the full 26-week supply on first order, rather than re-ordering monthly, is the most common pattern we see from serious researchers in DIFC, Business Bay and Jumeirah — and it removes any risk of a stock gap mid-protocol corrupting your dataset.
DEXA pricing in the UAE varies substantially by emirate and by whether the centre runs a VAT regional analysis (essential — a standard bone-density DEXA without the body-composition module is useless for tesamorelin tracking). Based on quotes pulled from clinics across Dubai, Abu Dhabi and Sharjah, expect the following ranges. Always confirm the centre runs a VAT-capable software module (GE CoreScan, Hologic InnerCore or equivalent).
| Emirate | Typical DEXA + VAT range | Notes |
|---|---|---|
| Dubai (Marina, DIFC, Jumeirah, Business Bay clinics) | AED 600 to 900 | Best machine availability; ask for GE Lunar iDXA or Hologic Horizon |
| Abu Dhabi | AED 550 to 850 | Several hospital-grade options on Reem and the corniche |
| Sharjah | AED 450 to 700 | Often the most competitive AED pricing in the UAE for repeat scans |
| Northern emirates (Ajman, RAK, UAQ, Fujairah) | AED 450 to 750 where available | Many researchers in RAK and Fujairah drive to Sharjah for the scan |
Four DEXA scans (baseline, week 13, 26, 52) at Dubai prices will run roughly AED 2,400 to AED 3,600 total — a rounding error against the cost of running a 52-week peptide protocol without any objective endpoint data.
REVIVE LAB UAE dispatches tesamorelin same-day from the Dubai facility on orders placed before the cut-off, and delivers across all seven emirates within the windows below. Cash on delivery, discreet anonymous packaging and cold-chain courier are standard on every order. Researchers in Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills and Arabian Ranches typically receive same-day; the rest of the UAE is next-day.
| Emirate / Area | Delivery window from order confirmation | Notes |
|---|---|---|
| Dubai (Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills, Arabian Ranches) | Same day, 4 to 8 hours | Same-day Dubai dispatch on orders before cut-off; tesamorelin same day delivery available |
| Abu Dhabi | Next day, within 24 hours | Cold-chain courier; tesamorelin 24h delivery |
| Sharjah | Same day or next morning | Frequently same-day where Dubai routes overlap |
| Ajman | Next day, within 24 hours | Discreet packaging standard |
| Ras Al Khaimah (RAK) | Next day, 18 to 24 hours | Cold-chain maintained end to end |
| Fujairah | Next day, 24 hours | Cold-chain maintained end to end |
| Umm Al Quwain (UAQ) | Next day, within 24 hours | Cash on delivery available |
| Al Ain | Next day, within 24 hours | Cash on delivery available |
If you are based in Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills or Arabian Ranches and your order is confirmed before our Dubai dispatch cut-off, the courier is usually at your door before evening. This is the operational backbone that makes REVIVE the default peptides Dubai supplier for researchers running time-sensitive protocols.
REVIVE LAB UAE is a UAE-based peptides supplier operating out of a Dubai facility, which is the single most underrated thing about us — your tesamorelin doesn't sit in airport customs for two weeks because it never crosses a border to reach you. Every vial is HPLC-tested and lot-documented; we keep tesamorelin 5 mg and 10 mg in continuous stock alongside retatrutide 5/10 mg, GHK-Cu 50/100 mg, BPC-157 5 mg, TB-500 5 mg, MOTS-c 10 mg, Semax 10 mg, NAD+ 100 mg and BAC water 3 mL. Cold-chain courier and discreet anonymous packaging are not upgrades — they're standard. Same-day Dubai dispatch and 24h delivery to the rest of the UAE are guaranteed on every confirmed order. Browse the full lineup at /products/ or jump straight to tesamorelin.
From REVIVE LAB UAE, the peptides UAE supplier shipping HPLC-tested tesamorelin 5 mg and 10 mg vials direct from the Dubai facility. Same-day Dubai dispatch covers Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills and Arabian Ranches; 24h delivery covers Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, UAQ and Al Ain. Cash on delivery and discreet anonymous packaging are standard. Order tesamorelin Dubai at /products/tesamorelin.html.
The published research cadence is baseline and week 26 (Falutz 2007, Stanley 2014), with Falutz 2010 extending observation to 52 weeks. For UAE researchers wanting an earlier responder signal, we recommend baseline, week 13, week 26 and week 52. That gives you four data points across a year-long protocol at a total imaging cost of roughly AED 2,400 to AED 3,600 across Dubai and Sharjah clinics.
Minimally. Tesamorelin's signature endpoint is visceral fat (VAT) loss, not whole-body weight loss. Expect one to three kilograms total weight change and one to two centimetres of waist change over 26 weeks — and a 15 to 18 percent VAT reduction on DEXA. This is exactly why DEXA tracking is non-optional if you want defensible data. Tape measures and scales will systematically under-report what the molecule did.